121 
0 Kommentare
$101M XPRIZE HEALTHSPAN AWARDS FIRST MILESTONE WINNERS DRIVING TOWARD REVOLUTIONARY HEALTHY AGING ADVANCES
Over 600 competing teams from 58 countries entered global competition. Teams with a broad range of potential solutions for healthspan extension awarded in first round.
NEW YORK, May 12, 2025 /PRNewswire/ -- XPRIZE, the world's leader in designing and operating large-scale incentive competitions to solve humanity's grand challenges, today announced the first Milestone award winners and top semifinalist teams competing in the next stage of its XPRIZE Healthspan, a $101 million, 7-year global competition incentivizing teams to develop and test therapeutics to improve healthy aging and close the gap between life and health expectancy. XPRIZE also announced the eight finalist teams competing for the $10M Facioscapulohumeral muscular dystrophy (FSHD) Bonus Prize. The announcement was made today at the XPRIZE Healthspan Awards Ceremony in New York City.
Global life expectancy has more than doubled in the last 100 years, but the quality of our health as we age has not increased at the same rate. In the U.S. there is currently a 12-year gap between life expectancy and healthy life expectancy, or the period of life free of major chronic disease or disability. Launched in November 2023, the $101M XPRIZE Healthspan is the first health-focused competition of its kind, incentivizing teams to develop proactive, accessible therapeutic solutions that restore muscle, cognition, and immune function by a minimum of 10 years, with a goal of 20 years, in persons aged 50-80 years, in one year or less.
"The next breakthrough in aging could come from scientists and entrepreneurs, anywhere. With this prize, we're igniting a global healthspan revolution, and these semifinalists are leading the charge," said Peter H. Diamandis, MD, founder and executive chairman of XPRIZE. "This competition isn't just accelerating progress, it's challenging our society's beliefs in what's possible when it comes to aging."
From over 600 registered teams across 58 countries, the Top 100 teams are recognized as semifinalists, with the Top 40 Healthspan teams and Top 8 FSHD Bonus Prize teams selected as Milestone 1 award winners based on their proposed therapeutic solution, scientific rationale, supporting evidence, strengths of team and clinical center, and proposals for clinical testing. Each Milestone 1 winner was awarded $250,000 to support their ongoing work and conduct clinical trials in the next phase of the competition.
Diskutieren Sie über die enthaltenen Werte
URL kopieren
Per E-Mail teilen
Artikel drucken